Cancer Treatment Research in South Carolina
Cancer Treatment Research (93.395) awarded $29.9 million to recipients in South Carolina in 32 grants from fiscal 2021 to 2025, 0.5% of the program's national total. The Medical University of South Carolina received the most, $17.8 million.
- Awarded in South Carolina$29.9 million
- Awards32
- Share of the program0.5%
- Rank among states28th of 50
- National total$5.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 14 | $7.0 million |
| FY 2022 | 19 | $6.0 million |
| FY 2023 | 12 | $4.8 million |
| FY 2024 | 13 | $5.7 million |
| FY 2025 | 14 | $6.4 million |
Recipients in South Carolina
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Medical University of South Carolina | Colleges and universities | 16 | $17.8 million |
| University of South Carolina | Colleges and universities | 3 | $3.0 million |
| Leukogene Therapeutics Inc | Small businesses | 3 | $2.8 million |
| Loxigen, Inc. | Small businesses | 1 | $2.5 million |
| Senex Biotechnology Inc | Small businesses | 3 | $1.6 million |
| Lipo-Immuno Tech LLC | Small businesses | 2 | $794,167 |
| Promilead, LLC | Small businesses | 1 | $400,000 |
| Ppi Pharmaceuticals LLC | Small businesses | 1 | $395,724 |
| Acepre, LLC | Small businesses | 1 | $392,803 |
| Furman University | Colleges and universities | 1 | $299,191 |
Open opportunities under this program
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Treatment Research money goes to South Carolina?
$29.9 million from fiscal 2021 to 2025, across 32 awards. South Carolina ranks 28th of 50 states and territories for this program.
Who receives Cancer Treatment Research money in South Carolina?
The largest recipient is The Medical University of South Carolina, with $17.8 million in 16 awards. Next are University of South Carolina and Leukogene Therapeutics Inc.
Can organizations in South Carolina apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Treatment Research in other states
Other large programs in South Carolina
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Head Start